Oral Oncology
Volume 45, Issue 1 , Pages 39-46 , January 2009

High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas

  • Kazunori Kidani

      Affiliations

    • Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori 683-8503, Japan
    • Division of Oral and Maxillofacial Biopathological Surgery, Department of Medicine of Sensory and Motor Organs, Tottori University, Faculty of Medicine, Yonago, Tottori 683-8503, Japan
    • Corresponding Author InformationCorresponding author. Address: Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori 683-8503, Japan. Tel.: +81 859 38 6053; fax: +81 859 38 6050.
    • ,
  • Mitsuhiko Osaki

      Affiliations

    • Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori 683-8503, Japan
    • Division of Molecular Genetics and Biofunction, Tottori University, Graduate School of Medical Science, Yonago, Tottori 683-8503, Japan
    • ,
  • Takayuki Tamura

      Affiliations

    • Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori 683-8503, Japan
    • ,
  • Kensaku Yamaga

      Affiliations

    • Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori 683-8503, Japan
    • ,
  • Kohei Shomori

      Affiliations

    • Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori 683-8503, Japan
    • ,
  • Kazuo Ryoke

      Affiliations

    • Division of Oral and Maxillofacial Biopathological Surgery, Department of Medicine of Sensory and Motor Organs, Tottori University, Faculty of Medicine, Yonago, Tottori 683-8503, Japan
    • ,
  • Hisao Ito

      Affiliations

    • Division of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori 683-8503, Japan

Received 29 January 2008 ,Revised 17 March 2008 ,Accepted 17 March 2008.

References 

  1. Sakai E, Rikimaru K, Ueda M, Matsumoto Y, Ishii N, Enomoto S, et al. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Int J Cancer. 1992;52:867–872
  2. Momose F, Araida T, Negishi A, Ichijo H, Shioda S, Sasaki S. Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J Oral Pathol Med. 1989;18:391–395
  3. Cohen EE, Lingen MW, Vokes EE. The expanding role of systemic therapy in head and neck cancer. J Clin Oncol. 2004;22:1743–1752
  4. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. New Engl J Med. 2004;350:1937–1944
  5. Banoczy J, Csiba A. Occurrence of epithelial dysplasia in oral leukoplakia, analysis and follow-up study of 12 cases. Oral Surg Oral Med Oral Pathol. 1976;42:766–774
  6. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer. 1984;53:563–568
  7. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:321–329
  8. Kodani I, Shomori K, Osaki M, Kuratate I, Ryoke K, Ito H. Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa. Pathobiology. 2001;69:150–158
  9. Shibata M, Kodani I, Osaki M, Araki K, Adachi H, Ryouke K, et al. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol. 2005;41:304–312
  10. Schliephake H. Prognostic relevance of molecular markers of oral cancer – a review. Int J Oral Maxillofac Surg. 2003;32:233–245
  11. Lo Muzio L, Santarelli A, Panzarella V, Campisi G, Carella M, Ciavarella D, et al. Oral squamous cell carcinoma and biological markers: an update on the molecules mainly involved in oral carcinogenesis. Minerva Stomatol. 2007;56:341–347
  12. Kudo Y, Takata T, Ogawa I, Sato S, Nikai H. Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas. Oncol Res. 1999;6:539–545
  13. Myoung H, Kim MJ, Lee JH, Ok YJ, Paeng JY, Yun PY. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients. Int J Oral Maxillofac Surg. 2006;35:1005–1010
  14. Mao C, Lu Y, Lai Q, Xia Y, Yang C. Expression of p53 gene in oral squamous cell carcinoma and its relation with clinical and pathological parameters and prognosis of patients. Chin Med Sci J. 1995;10:199–203
  15. Gonzalez-Moles MA, Galindo P, Gutierrez-Fernandez J, Sanches-Fernandes E, Rodriguez-Archilla A, Ruitz-Avila I, et al. P53 protein expression in oral squamous cell carcinoma. survival analysis. Anticancer Res. 2001;21:2889–2894
  16. Gonzalez-Moles MA, Caballero R, Rodriguez-Archilla A, Ruiz-Avila I, Bravo I. Prognosis value of the expression of Ki-67 for squamous cell carcinoma of the oral cavity. Acta Stomatol Belg. 1996;93:159–165
  17. Piffko J, Bankfalvi A, Ofner D, Kusch F, Bocker W, Joos U, et al. In situ assessment of cell proliferation at the invasive front of oral squamous cell carcinomas. Virchows Arch. 1996;429:229–234
  18. Simon JA, Tamkun JW. Programming off and on states in chromatin: mechanisms of polycomb and trithorax group complexes. Curr Opin Genet Dev. 2002;12:210–218
  19. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, et al. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science. 2002;298:1039–1043
  20. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419:624–629
  21. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA. 2003;100:11606–11611
  22. Raaphorst FM, Meijer CJ, Fieret E, Blokzijl T, Mommers E, et al. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia. 2003;5:481–488
  23. Matsukawa Y, Semba S, Kato H, Ito A, Yanagihara K, Yokozaki H. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Cancer Sci. 2006;97:484–491
  24. Sudo T, Utsunomiya T, Mimori K, et al. Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Brit J Cancer. 2005;92:1754–1758
  25. Arisan S, Buyuktuncer ED, Palavan-Unsal N, Caskurlu T, Cakir OO, Ergenekon E. Increased expression of EZH2, a polycomb group protein, in bladder carcinoma. Urol Int. 2005;75:252–257
  26. Weikert S, Christoph F, Kollermann J, Muller M, Schrader M, et al. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. Int J Mol Med. 2005;16:349–353
  27. Sobin LH, Fleming ID. TNM classification of malignant tumors, 5th ed. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803–4.
  28. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. Histological typing of cancer and precancer of the oral mucosa. 2nd ed.. Berlin: World Health Organization, Springer-Verlag; 1997;p. 24–40
  29. Jakobsson PA, Eneroth CM, Killander D, Moberger G, Martensson B. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol. 1973;12:1–8
  30. Kodani I, Osaki M, Shomori K, Araki K, Goto E, Ryoke K, et al. Minichromosome maintenance 2 expression is correlated with mode of invasion and prognosis in oral squamous cell carcinomas. J Oral Pathol Med. 2003;32:468–474
  31. Foster CS, Falconer A, Dodson AR, Norman AR, Dennis N, Fletcher A, et al. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene. 2004;23:5871–5879
  32. Breuer RH, Snijders RJ, Smit EF, Sutedja TG, Sewalt RG, Otte AP, et al. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis. Neoplasia. 2004;6:736–743
  33. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 2003;22:5323–5335
  34. Raman JD, Mongan NP, Tickoo SK, Boorjian SA, Scherr DS, Gudas LJ. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res. 2005;11:8570–8576
  35. Ding L, Erdmann C, Chinnaiyan AM, Merajver SD, Kleer CG. Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. Cancer Res. 2006;66:4095–4099
  36. Visser HP, Gunster MJ, Kluin-Nelemans HC, Monders EM, Raaphorst FM, Meijer CJ, et al. The polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Brit J Haematol. 2001;112:950–958
  37. Fukuyama T, Otsuka T, Shigematsu H, Arima F, Ohno Y, Iwasaki H, et al. Proliferative involvement of ENX-1, a putative human polycomb group gene, in haematopoietic cells. Brit J Haematol. 2002;108:842–847
  38. Kirmizis A, Bartley SM, Farnham PJ. Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol Cancer Ther. 2003;2:113–121

PII: S1368-8375(08)00095-X

doi: 10.1016/j.oraloncology.2008.03.016

Oral Oncology
Volume 45, Issue 1 , Pages 39-46 , January 2009

Article Tools

* Image Usage & Resolution